Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-798-3 | CAS number: 126-71-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Triisobutyl phosphate
- EC Number:
- 204-798-3
- EC Name:
- Triisobutyl phosphate
- Cas Number:
- 126-71-6
- Molecular formula:
- C12H27O4P
- IUPAC Name:
- triisobutyl phosphate
Constituent 1
- Specific details on test material used for the study:
- - Name of test material: MCS 2518
- Physical state: colorless liquid
- Analytical purity: 99.8%
- Lot/batch No.: MIC-5041454
- Storage condition of test material: room temperature
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Inc., Portage, MI.
- Age at study initiation: 8-12 weeks old
- Weight at study initiation: not specified
- Assigned to test groups randomly: yes, by a computer-generated randomization scheme.
- Fasting period before study: not specified
- Housing: two per cage prior to dosing and one per cage after dosing
- Diet (ad libitum): Purina Certified Laboratory Rodent Chow No. 5002 (Trademark of Purina Mills Inc., St. Louis, Mo.)
- Water (ad libitum): supplied by the public water system of St. Louis, MO
- Acclimation period: minimum of 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17.8-21.1
- Humidity (%): 40-70
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12-hour light cycle
IN-LIFE DATES: not specified
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: not specified
- Concentration of test material in vehicle: 10 mL/kg bw - Details on exposure:
- Animals were treated by a single intraperitoneal injection. Animals were sacrificed for micronucleus evaluation (five animals/sex/group) at 24, 48 and 72 hours after dosing.
- Duration of treatment / exposure:
- Single treatment
- Frequency of treatment:
- Doses were administered once.
- Post exposure period:
- up to 72 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 300 mg/kg bw (total dose)
- Dose / conc.:
- 600 mg/kg bw (total dose)
- Dose / conc.:
- 1 200 mg/kg bw (total dose)
- No. of animals per sex per dose:
- Test group: 15
Vehicle control: 15
Positive control: 5 - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide in saline
- Justification for choice of positive control(s): not specified
- Route of administration: intraperitoneal injection
- Doses / concentrations: 10 mL of solution/kg body weight
Examinations
- Tissues and cell types examined:
- Bone marrow from both femora of each animal were pooled for slide preparation.
For each animal, two scorers each evaluated:
- 500 total erythrocytes for polychromatic erythrocytes (PCEs) and normochromatic erythrocytes (NCEs)
- 500 PCEs for micronucleated polychromatic e rythrocytes (MN PCEs). - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Dose levels for the main study were selected based on toxicity rangefinding study data. The maximum dose selected for testing in the micronucleus experiment was 1200 mg/kg bw (approximately 69% of the combined calculated LD50 of 1730 mg/kg).
DETAILS OF SLIDE PREPARATION:
All animals were sacrificed by cervical dislocation and their femora were removed. Each bone was opened at the end and the bone marrow was flushed with approximately 2 ml of fetal bovine serum in a centrifuge tube. Bone marrow from both femora of each animal were pooled for slide preparation. The suspension was centrifuged to remove the serum. Portions of the remaining cells were placed on a clean glass microscope slide and a smear was prepared. Two slides were initially prepared for each sample and the remaining cell suspension was stored refrigerated to prepare additional slides if needed. Following preparation of the smears the slides were allowed to air dry overnight. The slides were stained using a HemaTek II slide staining machine and a Wright-Giemsa Stain Pak which includes stain, buffer and rinse solutions. - Evaluation criteria:
- To determine whether a statistically significant response in MN PCE frequency is treatment related the following criteria are considered:
- whether there are dose and time-dependent effects that are consistent with a treatment-induced response
- the degree of the response in relation to both concurrent and historical negative and positive control data - Statistics:
- Micronucleated PCE frequencies observed for each animal were transformed as the square root prior to analysis (Snedecor and Cochran; 1967, MacGregor et al., 1987). PCE/total erythrocyte ratios were not transformed. A Dunnett's test (one sided) was used for comparison of treatment group and positive control values with vehicle control values (Dunnett, 1955). A critical value of p≤0.05 was used for statistical significance.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
In the rangefinding experiments, the tes substance was found to be toxic to male and female CD-1 mice at 2000 mg/kg bw and greater as indicated by clinical signs of toxicity to the treated males and deaths in the treated males and females. Using the binomial method, the combined LD50 was determined to be 1730 mg/kg. Based on these results, a target dose of 1200 mg/kg (approximately 69% of the combined LD50 value) was selected as a maximum dose that would insure a reasonable probability of observing signs of toxicity but allow survival of the treated animals through the 72 hour time point. Two additional lower doses (300 and 600 mg/kg bw) were also selected for testing.
RESULTS OF DEFINITIVE STUDY
No deaths were observed in the treatment or control groups. All animals in the treatment and control groups appeared normal throughout the experiment and no statistically significant decreases in mean body weights compared to control group values were observed. No statistically significant decreases in mean PCE/erythrocyte ratios were observed in any of the test substance treatment groups.
No statistically significant increases in micronucleated PCE frequency were observed for test substance dosed groups at any of the sacrifice times. The positive control (cyclophosphamide) yielded expected positive responses in micronucleated PCE frequency indicating the adequacy of the experimental conditions.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
